TwinBeech Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Buy
+4,795
New +$272K 0.05% 350
2025
Q2
– Sell
-15,938
Closed -$481K – 811
2025
Q1
$481K Buy
+15,938
New +$522K 0.01% 580
2024
Q4
– Sell
-235,477
Closed -$9.43M – 763
2024
Q3
$9.43M Buy
+235,477
New +$11M 0.18% 150
2024
Q2
– Sell
-46,364
Closed -$2.01M – 659
2024
Q1
$2.01M Buy
46,364
+16,635
+56% +$793K 0.04% 342
2023
Q4
$1.5M Buy
+29,729
New +$1.42M 0.02% 443
2023
Q2
– Sell
-136,967
Closed -$4.9M – 729
2023
Q1
$4.9M Buy
+136,967
New +$5.14M 0.1% 246
2021
Q2
– Sell
-22,750
Closed -$1.02M – 543
2021
Q1
$1.02M Buy
+22,750
New +$1.27M 0.15% 190
2020
Q4
– Sell
-4,872
Closed -$231K – 513
2020
Q3
$231K Buy
+4,872
New +$271K 0.05% 376

Other funds holding IONS

TwinBeech Capital's IONS Position: Q3 2026 in Review

TwinBeech Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 4,795 shares worth $214K. The stake represents 0.05% of the portfolio and ranks #350 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in IONS as recently as Q1 2025.

TwinBeech Capital first reported a position in IONS in Q3 2020 and has held it in 8 quarters since. The position peaked at $9.43M in Q3 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • TwinBeech Capital held 4,795 shares of Ionis Pharmaceuticals worth $214K as of Q3 2026.
  • Ionis Pharmaceuticals was a new TwinBeech Capital position in Q3 2026.
  • Ionis Pharmaceuticals made up 0.05% of TwinBeech Capital's portfolio in Q3 2026, its #350 holding.
  • TwinBeech Capital first reported a position in Ionis Pharmaceuticals in Q3 2020 and has held it in 8 quarters since.
  • TwinBeech Capital's Ionis Pharmaceuticals position peaked at $9.43M in Q3 2024.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on TwinBeech Capital's 13F filing for Q3 2026, filed 16 Nov 2026.